Free Newsletter
Register for our Free Newsletters
Newsletter
Zones
Analysis, Inspection and Laboratory
LeftNav
Assisted/Independent Living
LeftNav
Clinical and Nursing Equipment
LeftNav
Design and Manufacture of Medical Equipment
LeftNav
Diagnostics Equipment, Monitoring and Test
LeftNav
Education, Training and Professional Services
LeftNav
Health Education and Patient Management
LeftNav
Health Estates Management
LeftNav
Healthcare Support and Information Services
LeftNav
Hygiene and Infection Control
LeftNav
IT and Communications in Healthcare
LeftNav
Materials
LeftNav
Medical Device Technology
LeftNav
Research and Development
LeftNav
Safety and Security
LeftNav
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone
 
 
News

Stereotaxis partnered magnetic irrigated catheter is cleared for use in the USA

Stereotaxis : 16 January, 2008  (New Product)
The US Food and Drug Administration (FDA) has approved Stereotaxis' partnered magnetic irrigated catheter for use in mapping and ablation in the USA.
'The long-awaited FDA approval of our partnered irrigated Catheter is a very significant milestone for Stereotaxis,' said Bevil J Hogg, chief executive officer of Stereotaxis. 'Since its approval and introduction in Europe, the irrigated Catheter has been used to successfully treat complex left-sided arrhythmias at a number of leading hospitals in Europe. Patient outcomes have been excellent. The Stereotaxis Magnetic Navigation System, used in conjunction with the magnetic irrigated Catheter and the company's latest software release has performed extremely well with a high degree of safety. We believe that these results will be duplicated at centres in the USA, and we are confident that the Stereotaxis Magnetic Navigation System with the irrigated Catheter has the potential to establish a new standard of care in the treatment of complex arrhythmias. A broad spectrum of thought leaders will present their initial experience with the magnetic irrigated Catheter in European centres during the Boston Atrial Fibrillation Symposium on January 17 and 18, and we eagerly look forward to their presentations.'

'There is significant pent-up demand for our solution among both existing and prospective customers,' continued Hogg. 'As a result, once the irrigated Catheter becomes broadly available in the USA, we anticipate a return to strong pipeline and order growth for our Magnetic Navigation System and accelerated growth in usage rates and related recurring revenues. We are highly confident that this momentum will be transformative for our company.'


Bookmark and Share
 
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
 
   © 2012 ProHealthServiceZone.com
Netgains Logo